← Russell 3000 cross-section

BRKR BRUKER CORP

Trailing twelve months to 2026-06-30 · as filed 2026-08-05, not restated
Healthcare

Scale

Market cap
$9.0bn
Revenue TTM
$3.5bn
Net income TTM
$-71m
Free cash flow
$94m
Composite score
40.6
Sector rank
#768

Valuation

P / E
EV / EBITDA
53.1
EV / sales
3.0
FCF yield
1.05%
Earnings yield vs 10-yr
-5.52pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-2.0%
EBITDA margin
5.7%
ROE
-3.0%
ROIC
-0.8%
Revenue growth
1.6%

Insider activity, last 90 days

Net open-market
$-0.54m
Buyers
0
Sellers
2

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

These measures include non-GAAP constant exchange rate (“CER”) currency revenue growth, non-GAAP organic revenue growth, non-GAAP gross profit, non-GAAP gross profit margin, non-GAAP operating income, non-GAAP operating margin, and non-GAAP free cash flow. Reconciliations of GAAP to Non-GAAP financial measures: GAAP revenue to non-GAAP CER currency and non-GAAP organic revenue: (a) Year-over-year (“YOY”) growth rates are calculated as the percentage increase (or decrease) in respective line items relative to GAAP revenue in the comparable prior year period. …BRUKER CORP, 10-Q, period ended 2026-06-30, filed 2026-08-05

Read the full passage →